J Guillermo Paez, Pasi A Jänne, Jeffrey C Lee, Sean Tracy, Heidi Greulich, Stacey Gabriel, Paula Herman, Frederic J Kaye, Neal Lindeman, Titus J Boggon, Katsuhiko Naoki, Hidefumi Sasaki, Yoshitaka Fujii, Michael J Eck, William R Sellers, Bruce E Johnson, Matthew Meyerson. Science 2004
Times Cited: 7488
Times Cited: 7488
Times Cited
Times Co-cited
Similarity
Mechanism for activation of the EGF receptor catalytic domain by the juxtamembrane segment.
Natalia Jura, Nicholas F Endres, Kate Engel, Sebastian Deindl, Rahul Das, Meindert H Lamers, David E Wemmer, Xuewu Zhang, John Kuriyan. Cell 2009
Natalia Jura, Nicholas F Endres, Kate Engel, Sebastian Deindl, Rahul Das, Meindert H Lamers, David E Wemmer, Xuewu Zhang, John Kuriyan. Cell 2009
3
Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor.
Jennifer Stamos, Mark X Sliwkowski, Charles Eigenbrot. J Biol Chem 2002
Jennifer Stamos, Mark X Sliwkowski, Charles Eigenbrot. J Biol Chem 2002
3
CH7233163 Overcomes Osimertinib-Resistant EGFR-Del19/T790M/C797S Mutation.
Kenji Kashima, Hiroki Kawauchi, Hiromi Tanimura, Yukako Tachibana, Takashi Chiba, Takuya Torizawa, Hiroshi Sakamoto. Mol Cancer Ther 2020
Kenji Kashima, Hiroki Kawauchi, Hiromi Tanimura, Yukako Tachibana, Takashi Chiba, Takuya Torizawa, Hiroshi Sakamoto. Mol Cancer Ther 2020
8
Efficacy, safety, and genetic analysis of furmonertinib (AST2818) in patients with EGFR T790M mutated non-small-cell lung cancer: a phase 2b, multicentre, single-arm, open-label study.
Yuankai Shi, Xingsheng Hu, Shucai Zhang, Dongqing Lv, Lin Wu, Qitao Yu, Yiping Zhang, Li Liu, Xiang Wang, Ying Cheng,[...]. Lancet Respir Med 2021
Yuankai Shi, Xingsheng Hu, Shucai Zhang, Dongqing Lv, Lin Wu, Qitao Yu, Yiping Zhang, Li Liu, Xiang Wang, Ying Cheng,[...]. Lancet Respir Med 2021
7
Architecture and membrane interactions of the EGF receptor.
Anton Arkhipov, Yibing Shan, Rahul Das, Nicholas F Endres, Michael P Eastwood, David E Wemmer, John Kuriyan, David E Shaw. Cell 2013
Anton Arkhipov, Yibing Shan, Rahul Das, Nicholas F Endres, Michael P Eastwood, David E Wemmer, John Kuriyan, David E Shaw. Cell 2013
3
Comparison of liquid-based to tissue-based biopsy analysis by targeted next generation sequencing in advanced non-small cell lung cancer: a comprehensive systematic review.
Stepan M Esagian, Georgia Ι Grigoriadou, Ilias P Nikas, Vasileios Boikou, Peter M Sadow, Jae-Kyung Won, Konstantinos P Economopoulos. J Cancer Res Clin Oncol 2020
Stepan M Esagian, Georgia Ι Grigoriadou, Ilias P Nikas, Vasileios Boikou, Peter M Sadow, Jae-Kyung Won, Konstantinos P Economopoulos. J Cancer Res Clin Oncol 2020
7
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer.
Julie Brahmer, Karen L Reckamp, Paul Baas, Lucio Crinò, Wilfried E E Eberhardt, Elena Poddubskaya, Scott Antonia, Adam Pluzanski, Everett E Vokes, Esther Holgado,[...]. N Engl J Med 2015
Julie Brahmer, Karen L Reckamp, Paul Baas, Lucio Crinò, Wilfried E E Eberhardt, Elena Poddubskaya, Scott Antonia, Adam Pluzanski, Everett E Vokes, Esther Holgado,[...]. N Engl J Med 2015
3
Rare epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer.
Peter T Harrison, Simon Vyse, Paul H Huang. Semin Cancer Biol 2020
Peter T Harrison, Simon Vyse, Paul H Huang. Semin Cancer Biol 2020
3
HER2 amplification: a potential mechanism of acquired resistance to EGFR inhibition in EGFR-mutant lung cancers that lack the second-site EGFRT790M mutation.
Ken Takezawa, Valentina Pirazzoli, Maria E Arcila, Caroline A Nebhan, Xiaoling Song, Elisa de Stanchina, Kadoaki Ohashi, Yelena Y Janjigian, Paula J Spitzler, Mary Ann Melnick,[...]. Cancer Discov 2012
Ken Takezawa, Valentina Pirazzoli, Maria E Arcila, Caroline A Nebhan, Xiaoling Song, Elisa de Stanchina, Kadoaki Ohashi, Yelena Y Janjigian, Paula J Spitzler, Mary Ann Melnick,[...]. Cancer Discov 2012
3
Management of acquired resistance to EGFR TKI-targeted therapy in advanced non-small cell lung cancer.
Shang-Gin Wu, Jin-Yuan Shih. Mol Cancer 2018
Shang-Gin Wu, Jin-Yuan Shih. Mol Cancer 2018
3
Osimertinib in Pretreated T790M-Positive Advanced Non-Small-Cell Lung Cancer: AURA Study Phase II Extension Component.
James Chih-Hsin Yang, Myung-Ju Ahn, Dong-Wan Kim, Suresh S Ramalingam, Lecia V Sequist, Wu-Chou Su, Sang-We Kim, Joo-Hang Kim, David Planchard, Enriqueta Felip,[...]. J Clin Oncol 2017
James Chih-Hsin Yang, Myung-Ju Ahn, Dong-Wan Kim, Suresh S Ramalingam, Lecia V Sequist, Wu-Chou Su, Sang-We Kim, Joo-Hang Kim, David Planchard, Enriqueta Felip,[...]. J Clin Oncol 2017
3
RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer.
Matthew J Niederst, Lecia V Sequist, John T Poirier, Craig H Mermel, Elizabeth L Lockerman, Angel R Garcia, Ryohei Katayama, Carlotta Costa, Kenneth N Ross, Teresa Moran,[...]. Nat Commun 2015
Matthew J Niederst, Lecia V Sequist, John T Poirier, Craig H Mermel, Elizabeth L Lockerman, Angel R Garcia, Ryohei Katayama, Carlotta Costa, Kenneth N Ross, Teresa Moran,[...]. Nat Commun 2015
3
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
D Planchard, S Popat, K Kerr, S Novello, E F Smit, C Faivre-Finn, T S Mok, M Reck, P E Van Schil, M D Hellmann,[...]. Ann Oncol 2018
D Planchard, S Popat, K Kerr, S Novello, E F Smit, C Faivre-Finn, T S Mok, M Reck, P E Van Schil, M D Hellmann,[...]. Ann Oncol 2018
3
The architecture of EGFR's basal complexes reveals autoinhibition mechanisms in dimers and oligomers.
Laura C Zanetti-Domingues, Dimitrios Korovesis, Sarah R Needham, Christopher J Tynan, Shiori Sagawa, Selene K Roberts, Antonija Kuzmanic, Elena Ortiz-Zapater, Purvi Jain, Rob C Roovers,[...]. Nat Commun 2018
Laura C Zanetti-Domingues, Dimitrios Korovesis, Sarah R Needham, Christopher J Tynan, Shiori Sagawa, Selene K Roberts, Antonija Kuzmanic, Elena Ortiz-Zapater, Purvi Jain, Rob C Roovers,[...]. Nat Commun 2018
6
Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab.
Hyun-Soo Cho, Karen Mason, Kasra X Ramyar, Ann Marie Stanley, Sandra B Gabelli, Dan W Denney, Daniel J Leahy. Nature 2003
Hyun-Soo Cho, Karen Mason, Kasra X Ramyar, Ann Marie Stanley, Sandra B Gabelli, Dan W Denney, Daniel J Leahy. Nature 2003
3
STAR: ultrafast universal RNA-seq aligner.
Alexander Dobin, Carrie A Davis, Felix Schlesinger, Jorg Drenkow, Chris Zaleski, Sonali Jha, Philippe Batut, Mark Chaisson, Thomas R Gingeras. Bioinformatics 2013
Alexander Dobin, Carrie A Davis, Felix Schlesinger, Jorg Drenkow, Chris Zaleski, Sonali Jha, Philippe Batut, Mark Chaisson, Thomas R Gingeras. Bioinformatics 2013
3
Oncogenic Signaling Pathways in The Cancer Genome Atlas.
Francisco Sanchez-Vega, Marco Mina, Joshua Armenia, Walid K Chatila, Augustin Luna, Konnor C La, Sofia Dimitriadoy, David L Liu, Havish S Kantheti, Sadegh Saghafinia,[...]. Cell 2018
Francisco Sanchez-Vega, Marco Mina, Joshua Armenia, Walid K Chatila, Augustin Luna, Konnor C La, Sofia Dimitriadoy, David L Liu, Havish S Kantheti, Sadegh Saghafinia,[...]. Cell 2018
3
Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship.
Julian R Molina, Ping Yang, Stephen D Cassivi, Steven E Schild, Alex A Adjei. Mayo Clin Proc 2008
Julian R Molina, Ping Yang, Stephen D Cassivi, Steven E Schild, Alex A Adjei. Mayo Clin Proc 2008
3
The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification.
N Prenzel, O M Fischer, S Streit, S Hart, A Ullrich. Endocr Relat Cancer 2001
N Prenzel, O M Fischer, S Streit, S Hart, A Ullrich. Endocr Relat Cancer 2001
3
Mechanisms of receptor tyrosine kinase activation in cancer.
Zhenfang Du, Christine M Lovly. Mol Cancer 2018
Zhenfang Du, Christine M Lovly. Mol Cancer 2018
3
Rebiopsy of lung cancer patients with acquired resistance to EGFR inhibitors and enhanced detection of the T790M mutation using a locked nucleic acid-based assay.
Maria E Arcila, Geoffrey R Oxnard, Khedoudja Nafa, Gregory J Riely, Stephen B Solomon, Maureen F Zakowski, Mark G Kris, William Pao, Vincent A Miller, Marc Ladanyi. Clin Cancer Res 2011
Maria E Arcila, Geoffrey R Oxnard, Khedoudja Nafa, Gregory J Riely, Stephen B Solomon, Maureen F Zakowski, Mark G Kris, William Pao, Vincent A Miller, Marc Ladanyi. Clin Cancer Res 2011
3
First-line gefitinib in patients with advanced non-small-cell lung cancer harboring somatic EGFR mutations.
Lecia V Sequist, Renato G Martins, David Spigel, Steven M Grunberg, Alexander Spira, Pasi A Jänne, Victoria A Joshi, David McCollum, Tracey L Evans, Alona Muzikansky,[...]. J Clin Oncol 2008
Lecia V Sequist, Renato G Martins, David Spigel, Steven M Grunberg, Alexander Spira, Pasi A Jänne, Victoria A Joshi, David McCollum, Tracey L Evans, Alona Muzikansky,[...]. J Clin Oncol 2008
3
Acquired BRAF V600E Mutation as Resistant Mechanism after Treatment with Osimertinib.
Chao-Chi Ho, Wei-Yu Liao, Chih-An Lin, Jin-Yuan Shih, Chong-Jen Yu, James Chih-Hsin Yang. J Thorac Oncol 2017
Chao-Chi Ho, Wei-Yu Liao, Chih-An Lin, Jin-Yuan Shih, Chong-Jen Yu, James Chih-Hsin Yang. J Thorac Oncol 2017
3
Activity of a novel HER2 inhibitor, poziotinib, for HER2 exon 20 mutations in lung cancer and mechanism of acquired resistance: An in vitro study.
Takamasa Koga, Yoshihisa Kobayashi, Kenji Tomizawa, Kenichi Suda, Takayuki Kosaka, Yuichi Sesumi, Toshio Fujino, Masaya Nishino, Shuta Ohara, Masato Chiba,[...]. Lung Cancer 2018
Takamasa Koga, Yoshihisa Kobayashi, Kenji Tomizawa, Kenichi Suda, Takayuki Kosaka, Yuichi Sesumi, Toshio Fujino, Masaya Nishino, Shuta Ohara, Masato Chiba,[...]. Lung Cancer 2018
6
First-line icotinib versus cisplatin/pemetrexed plus pemetrexed maintenance therapy for patients with advanced EGFR mutation-positive lung adenocarcinoma (CONVINCE): a phase 3, open-label, randomized study.
Y K Shi, L Wang, B H Han, W Li, P Yu, Y P Liu, C M Ding, X Song, Z Y Ma, X L Ren,[...]. Ann Oncol 2017
Y K Shi, L Wang, B H Han, W Li, P Yu, Y P Liu, C M Ding, X Song, Z Y Ma, X L Ren,[...]. Ann Oncol 2017
3
New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer.
Anushka Dongre, Robert A Weinberg. Nat Rev Mol Cell Biol 2019
Anushka Dongre, Robert A Weinberg. Nat Rev Mol Cell Biol 2019
3
Nivolumab Plus Erlotinib in Patients With EGFR-Mutant Advanced NSCLC.
Scott Gettinger, Matthew D Hellmann, Laura Q M Chow, Hossein Borghaei, Scott Antonia, Julie R Brahmer, Jonathan W Goldman, David E Gerber, Rosalyn A Juergens, Frances A Shepherd,[...]. J Thorac Oncol 2018
Scott Gettinger, Matthew D Hellmann, Laura Q M Chow, Hossein Borghaei, Scott Antonia, Julie R Brahmer, Jonathan W Goldman, David E Gerber, Rosalyn A Juergens, Frances A Shepherd,[...]. J Thorac Oncol 2018
3
Suppression of STING Associated with LKB1 Loss in KRAS-Driven Lung Cancer.
Shunsuke Kitajima, Elena Ivanova, Sujuan Guo, Ryohei Yoshida, Marco Campisi, Shriram K Sundararaman, Shoichiro Tange, Yoichiro Mitsuishi, Tran C Thai, Sayuri Masuda,[...]. Cancer Discov 2019
Shunsuke Kitajima, Elena Ivanova, Sujuan Guo, Ryohei Yoshida, Marco Campisi, Shriram K Sundararaman, Shoichiro Tange, Yoichiro Mitsuishi, Tran C Thai, Sayuri Masuda,[...]. Cancer Discov 2019
3
Treatment-Induced Tumor Dormancy through YAP-Mediated Transcriptional Reprogramming of the Apoptotic Pathway.
Kari J Kurppa, Yao Liu, Ciric To, Tinghu Zhang, Mengyang Fan, Amir Vajdi, Erik H Knelson, Yingtian Xie, Klothilda Lim, Paloma Cejas,[...]. Cancer Cell 2020
Kari J Kurppa, Yao Liu, Ciric To, Tinghu Zhang, Mengyang Fan, Amir Vajdi, Erik H Knelson, Yingtian Xie, Klothilda Lim, Paloma Cejas,[...]. Cancer Cell 2020
3
Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer.
Eunice L Kwak, Yung-Jue Bang, D Ross Camidge, Alice T Shaw, Benjamin Solomon, Robert G Maki, Sai-Hong I Ou, Bruce J Dezube, Pasi A Jänne, Daniel B Costa,[...]. N Engl J Med 2010
Eunice L Kwak, Yung-Jue Bang, D Ross Camidge, Alice T Shaw, Benjamin Solomon, Robert G Maki, Sai-Hong I Ou, Bruce J Dezube, Pasi A Jänne, Daniel B Costa,[...]. N Engl J Med 2010
3
EGFR C797S mutation mediates resistance to third-generation inhibitors in T790M-positive non-small cell lung cancer.
Shuhang Wang, Stella T Tsui, Christina Liu, Yongping Song, Delong Liu. J Hematol Oncol 2016
Shuhang Wang, Stella T Tsui, Christina Liu, Yongping Song, Delong Liu. J Hematol Oncol 2016
3
Epidermal growth factor receptor (EGFR) signaling in cancer.
Nicola Normanno, Antonella De Luca, Caterina Bianco, Luigi Strizzi, Mario Mancino, Monica R Maiello, Adele Carotenuto, Gianfranco De Feo, Francesco Caponigro, David S Salomon. Gene 2006
Nicola Normanno, Antonella De Luca, Caterina Bianco, Luigi Strizzi, Mario Mancino, Monica R Maiello, Adele Carotenuto, Gianfranco De Feo, Francesco Caponigro, David S Salomon. Gene 2006
3
3
EGFR G796D mutation mediates resistance to osimertinib.
Di Zheng, Min Hu, Yu Bai, Xuehua Zhu, Xuesong Lu, Chunyan Wu, Jiying Wang, Li Liu, Zheng Wang, Jian Ni,[...]. Oncotarget 2017
Di Zheng, Min Hu, Yu Bai, Xuehua Zhu, Xuesong Lu, Chunyan Wu, Jiying Wang, Li Liu, Zheng Wang, Jian Ni,[...]. Oncotarget 2017
4
GSVA: gene set variation analysis for microarray and RNA-seq data.
Sonja Hänzelmann, Robert Castelo, Justin Guinney. BMC Bioinformatics 2013
Sonja Hänzelmann, Robert Castelo, Justin Guinney. BMC Bioinformatics 2013
3
AACR Project GENIE: Powering Precision Medicine through an International Consortium.
. Cancer Discov 2017
. Cancer Discov 2017
3
Somatic mutations affect key pathways in lung adenocarcinoma.
Li Ding, Gad Getz, David A Wheeler, Elaine R Mardis, Michael D McLellan, Kristian Cibulskis, Carrie Sougnez, Heidi Greulich, Donna M Muzny, Margaret B Morgan,[...]. Nature 2008
Li Ding, Gad Getz, David A Wheeler, Elaine R Mardis, Michael D McLellan, Kristian Cibulskis, Carrie Sougnez, Heidi Greulich, Donna M Muzny, Margaret B Morgan,[...]. Nature 2008
3
Studying clonal dynamics in response to cancer therapy using high-complexity barcoding.
Hyo-eun C Bhang, David A Ruddy, Viveksagar Krishnamurthy Radhakrishna, Justina X Caushi, Rui Zhao, Matthew M Hims, Angad P Singh, Iris Kao, Daniel Rakiec, Pamela Shaw,[...]. Nat Med 2015
Hyo-eun C Bhang, David A Ruddy, Viveksagar Krishnamurthy Radhakrishna, Justina X Caushi, Rui Zhao, Matthew M Hims, Angad P Singh, Iris Kao, Daniel Rakiec, Pamela Shaw,[...]. Nat Med 2015
3
Prospective Comprehensive Molecular Characterization of Lung Adenocarcinomas for Efficient Patient Matching to Approved and Emerging Therapies.
Emmet J Jordan, Hyunjae R Kim, Maria E Arcila, David Barron, Debyani Chakravarty, JianJiong Gao, Matthew T Chang, Andy Ni, Ritika Kundra, Philip Jonsson,[...]. Cancer Discov 2017
Emmet J Jordan, Hyunjae R Kim, Maria E Arcila, David Barron, Debyani Chakravarty, JianJiong Gao, Matthew T Chang, Andy Ni, Ritika Kundra, Philip Jonsson,[...]. Cancer Discov 2017
3
Lung Adenocarcinoma Harboring EGFR 19del/C797S/T790M Triple Mutations Responds to Brigatinib and Anti-EGFR Antibody Combination Therapy.
Xiaofei Wang, Ling Zhou, Jiani C Yin, Xue Wu, Yang W Shao, Beili Gao. J Thorac Oncol 2019
Xiaofei Wang, Ling Zhou, Jiani C Yin, Xue Wu, Yang W Shao, Beili Gao. J Thorac Oncol 2019
11
Overcoming therapy resistance in EGFR-mutant lung cancer.
Antonio Passaro, Pasi A Jänne, Tony Mok, Solange Peters. Nat Cancer 2021
Antonio Passaro, Pasi A Jänne, Tony Mok, Solange Peters. Nat Cancer 2021
5
Notch3-dependent β-catenin signaling mediates EGFR TKI drug persistence in EGFR mutant NSCLC.
Rajeswara Rao Arasada, Konstantin Shilo, Tadaaki Yamada, Jianying Zhang, Seiji Yano, Rashelle Ghanem, Walter Wang, Shinji Takeuchi, Koji Fukuda, Nobuyuki Katakami,[...]. Nat Commun 2018
Rajeswara Rao Arasada, Konstantin Shilo, Tadaaki Yamada, Jianying Zhang, Seiji Yano, Rashelle Ghanem, Walter Wang, Shinji Takeuchi, Koji Fukuda, Nobuyuki Katakami,[...]. Nat Commun 2018
7
Amplification of EGFR Wild-Type Alleles in Non-Small Cell Lung Cancer Cells Confers Acquired Resistance to Mutation-Selective EGFR Tyrosine Kinase Inhibitors.
Shigenari Nukaga, Hiroyuki Yasuda, Katsuya Tsuchihara, Junko Hamamoto, Keita Masuzawa, Ichiro Kawada, Katsuhiko Naoki, Shingo Matsumoto, Sachiyo Mimaki, Shinnosuke Ikemura,[...]. Cancer Res 2017
Shigenari Nukaga, Hiroyuki Yasuda, Katsuya Tsuchihara, Junko Hamamoto, Keita Masuzawa, Ichiro Kawada, Katsuhiko Naoki, Shingo Matsumoto, Sachiyo Mimaki, Shinnosuke Ikemura,[...]. Cancer Res 2017
3
Combined EGFR/MEK Inhibition Prevents the Emergence of Resistance in EGFR-Mutant Lung Cancer.
Erin M Tricker, Chunxiao Xu, Sharmeen Uddin, Marzia Capelletti, Dalia Ercan, Atsuko Ogino, Christine A Pratilas, Neal Rosen, Nathanael S Gray, Kwok-Kin Wong,[...]. Cancer Discov 2015
Erin M Tricker, Chunxiao Xu, Sharmeen Uddin, Marzia Capelletti, Dalia Ercan, Atsuko Ogino, Christine A Pratilas, Neal Rosen, Nathanael S Gray, Kwok-Kin Wong,[...]. Cancer Discov 2015
3
Tolerable and Effective Combination of Full-Dose Crizotinib and Osimertinib Targeting MET Amplification Sequentially Emerging after T790M Positivity in EGFR-Mutant Non-Small Cell Lung Cancer.
Emily R York, Marileila Varella-Garcia, Tami J Bang, Dara L Aisner, D Ross Camidge. J Thorac Oncol 2017
Emily R York, Marileila Varella-Garcia, Tami J Bang, Dara L Aisner, D Ross Camidge. J Thorac Oncol 2017
5
Mechanisms of resistance to EGFR-targeted drugs: lung cancer.
Floriana Morgillo, Carminia Maria Della Corte, Morena Fasano, Fortunato Ciardiello. ESMO Open 2016
Floriana Morgillo, Carminia Maria Della Corte, Morena Fasano, Fortunato Ciardiello. ESMO Open 2016
3
GOPC-ROS1 Rearrangement as an Acquired Resistance Mechanism to Osimertinib and Responding to Crizotinib Combined Treatments in Lung Adenocarcinoma.
Liang Zeng, Nong Yang, Yongchang Zhang. J Thorac Oncol 2018
Liang Zeng, Nong Yang, Yongchang Zhang. J Thorac Oncol 2018
9
Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial.
Achim Rittmeyer, Fabrice Barlesi, Daniel Waterkamp, Keunchil Park, Fortunato Ciardiello, Joachim von Pawel, Shirish M Gadgeel, Toyoaki Hida, Dariusz M Kowalski, Manuel Cobo Dols,[...]. Lancet 2017
Achim Rittmeyer, Fabrice Barlesi, Daniel Waterkamp, Keunchil Park, Fortunato Ciardiello, Joachim von Pawel, Shirish M Gadgeel, Toyoaki Hida, Dariusz M Kowalski, Manuel Cobo Dols,[...]. Lancet 2017
3
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.